Results 141 to 150 of about 5,025 (225)

What is the impact of blood pressure on neurological symptoms and the risk of ESKD in primary and secondary thrombotic microangiopathies based on clinical presentation: a retrospective study. [PDF]

BMC Nephrol, 2022
Halimi JM, Thoreau B, von Tokarski F, Bauvois A, Gueguen J, Goin N, Barbet C, Cloarec S, Mérieau E, Lachot S, Garot D, Lemaignen A, Gyan E, Perrotin F, Pouplard C, Maillot F, Gatault P, Sautenet B, Rusch E, Frémeaux-Bacchi V, Vigneau C, Bayer G, Fakhouri F.   +22 more
europepmc   +1 more source

Diagnosis and treatment of complement-mediated thrombotic microangiopathies: consensus of the Genetic Diseases Committee of the Chilean Society of Nephrology. [PDF]

BMC Nephrol
Musalem P, Bascur N, Sepúlveda RA, Krall P, Lazcano A, Navarro G, Rojo A, Grandy J.   +7 more
europepmc   +1 more source

Retrospective and Systematic Analysis of Causes and Outcomes of Thrombotic Microangiopathies in Routine Clinical Practice: An 11-Year Study. [PDF]

Front Med (Lausanne), 2021
Henry N, Mellaza C, Fage N, Beloncle F, Genevieve F, Legendre G, Orvain C, Garnier AS, Cousin M, Besson V, Subra JF, Duveau A, Augusto JF, Brilland B.   +13 more
europepmc   +1 more source

Cytokine storm and microvascular fate: mechanistic insights into endothelial injury in thrombotic microangiopathies. [PDF]

Ann Med Surg (Lond)
Obeagu EI.
europepmc   +1 more source

Educational Case: Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies and Potential Role of the Spleen. [PDF]

Acad Pathol, 2021
Nichols MM, Crane GM.
europepmc   +1 more source

<i>In vitro</i> exploration of drug-induced thrombotic microangiopathies: clues of diverse endothelial activation pathways respective to interferon-β1a, ciclosporin A, and gemcitabine exposure. [PDF]

Front Pharmacol
Cubilier E, Taghavi M, De Prez E, Jacobs L, Sinaeve S, Nortier J, Antoine MH.   +6 more
europepmc   +1 more source

Exchange transfusion for neonate with haemolytic uremic syndrome [PDF]

, 2016
Archna Sharma, Bedangshu Saikia, Neeraj Gupta, Neetu Vashisht   +3 more
core   +1 more source

The impact of the COVID-19 pandemic on incidence and clinical presentation of thrombotic microangiopathies: data from a laboratory centralizing ADAMTS-13 testing in Quebec. [PDF]

Orphanet J Rare Dis
Merlen C, Thouzeau-Benghezal S, Pépin E, Guay S, Lapeyraque AL, Cambier A, Rivard GE, Troyanov S, Bonnefoy A.   +8 more
europepmc   +1 more source

Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab. [PDF]

, 2010
Ahmad, Allford, Amorosi, Arici, Arnold, Bell, Bianchi, Caramazza, Cataland, Chemnitz, Chow, Cines, Clark, Daraibi, Elkins, Elliott, Fankouri, Furlan, Garvey, George, Gutterman, Hayward, Heidel, Jasti, Kameda, Kappers-Klunne, Koulova, Lalmuanpuii, Lankford, Lara, Ling, Lämmle, Mannucci, McDonald, McMinn, Millward, Moake, Moore, Mori, Niewold, Patino, Pereira, Quintini, Raife, Raife, Reddy, Rick, Rizvi, Rock, Rock, Ruiz, Rüfer, Sadler, Sadler, Sallah, Scaramucci, Scott, Scully, Thompson, Tsai, Tsai, Tsai, Vesely, Veyradier, Yassa, Yomtovian   +65 more
core   +1 more source